Spanish price discounts have silver lining for generic medicines industry
This article was originally published in Scrip
Executive Summary
Government spending on pharmaceuticals is continuing to fall in Spain, thanks to price discounts introduced last year. But the situation appears to be a double edged sword for the generic medicines industry, which has seen its volume share of the market increase while its value share remains stagnant.